$18.09 -0.25 (-1.36%)
11/27/2009 1:00 PM

Regeneron Pharmaceuticals, Inc. (REGN)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Featured Broker Partners